Divi's Laboratories Limited

₹10,320As of Sun 8 Nov 2026, 12:00 UTC
NSE:DIVISLABHealthcare
Country India
PE (Fwd) •••
TSR 10Y CAGR 23.74%
Div yield 0.29%
ROE 20.13%
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.18
PE TTM 81.44
TSR TTM 51.12%
Mkt cap ₹2.740T
ROIC 21.46%
SE Grade™
Value
Quality
Moat
Consensus
Reference
₹12,186
18.08%
(67.99%)
Hold 8|11|12|1|4
3Q26
4Q26
1Q27
2Q27
Earnings per share₹
176.08
181.91
187.24
177.93
5.50%
1.23%
6.86%
(1.84%)
Revenue₹B
129.2
130.4
135.3
143.3
8.03%
5.38%
6.18%
10.08%
Peers (US$29.17B)
Cap (US$)
PE
47.52B
40.70x
13.46B
94.44x
Capital
TTM
5Y
10Y
Leveragex
4.473
0.147
0.146
EBIT/Intx
3.152
0.352
0.354
Own earn%
(3.35)
107.13
98.48
Sh yield%
39.37
29.16
30.12
Owners
Insiders/Inst%
5.01
54.74
Short interest%
5.53
SBC / revenue%
1.09
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
2
Op margin range%
27–32
$1 testx
0.2
Incr. ROIC%
2